BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68
10 results:

  • 1. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
    Yao Y; Wang Y; Ye L; Lu B; Lu W
    Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating ddx5.
    Che Y; Bai M; Lu K; Fu L
    Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study.
    Brodeur MN; Samouëlian V; Dabi Y; Cormier B; Beauchemin MC; Barkati M
    Int J Gynecol Cancer; 2021 Jan; 31(1):78-84. PubMed ID: 33127863
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Proteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection.
    Qing S; Tulake W; Ru M; Li X; Yuemaier R; Lidifu D; Rouzibilali A; Hasimu A; Yang Y; Rouziahong R; Upur H; Abudula A
    Tumour Biol; 2017 Apr; 39(4):1010428317697547. PubMed ID: 28443473
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The expression of RNA helicase ddx5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells.
    González-Duarte RJ; Cázares-Ordoñez V; Díaz L; Ortíz V; Larrea F; Avila E
    Mol Cell Biochem; 2015 Dec; 410(1-2):65-73. PubMed ID: 26314252
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping.
    Ge S; Gong B; Cai X; Yang X; Gan X; Tong X; Li H; Zhu M; Yang F; Zhou H; Hong G
    Cancer Med; 2012 Aug; 1(1):59-67. PubMed ID: 23342254
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cell-mediated immune response to human papillomavirus 16 E7 peptide pools in patients with cervical neoplasia.
    Lee YS; Lee CW; Song MJ; Ho EM; Kim CJ; Park TC; Kim TG; Park JS
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1350-6. PubMed ID: 21916856
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India.
    Sankaranarayanan R; Nene BM; Dinshaw K; Rajkumar R; Shastri S; Wesley R; Basu P; Sharma R; Thara S; Budukh A; Parkin DM
    Salud Publica Mex; 2003; 45 Suppl 3():S399-407. PubMed ID: 14746033
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Positive and negative regulation of the human heme oxygenase-1 gene expression in cultured cells.
    Takahashi S; Takahashi Y; Ito K; Nagano T; Shibahara S; Miura T
    Biochim Biophys Acta; 1999 Oct; 1447(2-3):231-5. PubMed ID: 10542320
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. 1.5-5 years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancer.
    Piver MS; Lele SB; Patsner B; McPhee ME
    Gynecol Oncol; 1987 May; 27(1):24-33. PubMed ID: 3570047
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.